Systemic delivery of non-viral vector expressing SARS viral genomic vaccine

摘要

The present invention relates to a non-viral vector for SARS Viral Genomic Vaccine. The present invention also relates to a non-targeted lipoplex or PEGylated lipoplex formulation for accumulating SARS spike genome in the lung to that results in expression of SARS spike protein.